Regeneron Pharmaceuticals Inc 2020 SR
The report highlights Regeneron's 2020 sustainability progress, focusing on its response to the COVID-19 pandemic, including the development of the REGEN-COV antibody cocktail. The company advanced its 2025 global responsibility goals across three focus areas: improving lives, fostering integrity, and building sustainable communities. Key achievements include reinvesting 32% of revenue into R&D, sequencing 1.4 million exomes through the Regeneron Genetics Center, and achieving zero-waste-to-landfill status across all sites. Regeneron also accelerated its Diversity, Equity, and Inclusion efforts by hiring its first Chief DE&I Officer and increased its renewable energy usage to 20.5%.
Company: Regeneron Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2020
Type: SR
Pages: 94
Back to company
Regeneron Pharmaceuticals Inc
Responsibility Report
The report highlights Regeneron's 2020 sustainability progress, focusing on its response to the COVID-19 pandemic, including the development of the REGEN-COV antibody cocktail. The company advanced its 2025 global responsibility goals across three focus areas: improving lives, fostering integrity, and building sustainable communities. Key achievements include reinvesting 32% of revenue into R&D, sequencing 1.4 million exomes through the Regeneron Genetics Center, and achieving zero-waste-to-landfill status across all sites. Regeneron also accelerated its Diversity, Equity, and Inclusion efforts by hiring its first Chief DE&I Officer and increased its renewable energy usage to 20.5%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Apr 1, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees